erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
.
.
worried about how helen was doing after doctors performed surgery on her colon the same day he was admitted, robert, whose condition stabilized, had a simple request for his nurse: